Copy number aberration (CNA) profiling and variant analysis using next-generation sequencing (NGS) showed that these cells did not harbor the alterations exhibited by the primary tumor (<i>PIK3CA</i> G1049A mutation, <i>MYC</i> copy number gain). The gene discussed is MYC; the disease is neoplasm.